title: Compassionate use of vismodegib and adjuvant radiotherapy in the treatment of multiple locally advanced and inoperable basal cell carcinomas and squamous cell carcinomas of the skin.
authors.affiliation: Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Gathings
authors.affiliation: Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
authors.forename: Courtney S
authors.initials: CS
authors.lastname: Orscheln
authors.affiliation: Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. Electronic address: whuang@wakehealth.edu.
authors.forename: William W
authors.initials: WW
authors.lastname: Huang
mesh_terms: D000369:Aged, 80 and over; D000813:Anilides / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D003131:Combined Modality Therapy; D057176:Compassionate Use Trials; D005145:Face; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011725:Pyridines / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D019452:Terminally Ill; D016896:Treatment Outcome
chemical_list: D000813:Anilides; C538724:HhAntag691; D011725:Pyridines